|
Market Closed -
NYSE
16:30:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 11.45 USD | -1.55% |
|
-0.17% | -22.37% |
| 08-31 | Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-30 | Daxor Launches Blood Testing Lab in Eastern Kansis | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 3.68% | 3.92% | - | - | - | - | - | 4.84B | |
| 7.41% | 7.66% | 13.59x | 1.04x | 12.32x | - | 14.69x | 3.37B | |
| 6.32% | 6.44% | - | - | - | - | - | 3.34B | |
| 14.82% | 13.5% | -12.36x | 0.64x | 8.4x | - | 20.22x | 3.24B | |
| Average | 8.06% | 7.88% | 0.61x | 0.84x | 10.36x | 17.46x | 3.7B | ||
| Weighted average by Cap. | 7.57% | 7.44% | 0.86x | 0.84x | 10.40x | 17.40x |
- Stock Market
- Stocks
- DXR Stock
- DXR Stock
- Sector Daxor Corporation
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
